Total Payments
$1,277
2024 Payments
$720.15
Companies
18
Transactions
85
Medicare Patients
827
Medicare Billing
$49,617
Payment Breakdown by Category
Food & Beverage$1,277 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,277 | 85 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $386.92 | 31 | $0 (2024) |
| Novo Nordisk Inc | $211.89 | 15 | $0 (2024) |
| Lilly USA, LLC | $81.01 | 4 | $0 (2024) |
| PFIZER INC. | $73.95 | 5 | $0 (2024) |
| Exact Sciences Corporation | $67.33 | 3 | $0 (2024) |
| Lundbeck LLC | $67.06 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $57.82 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $50.74 | 3 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $50.29 | 3 | $0 (2024) |
| Axsome Therapeutics, Inc. | $40.45 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $720.15 | 50 | ABBVIE INC. ($154.45) |
| 2023 | $529.61 | 33 | ABBVIE INC. ($232.47) |
| 2021 | $27.35 | 2 | Lilly USA, LLC ($15.47) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: Oncology | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: PAIN | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: PAIN | ||||||
| 07/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.46 | General |
| Category: PSYCHIATRY | ||||||
| 06/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Oncology | ||||||
| 06/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 35 | $6,965 | $2,346 |
| 2022 | 6 | 379 | 389 | $53,690 | $22,340 |
| 2021 | 9 | 267 | 432 | $30,507 | $15,357 |
| 2020 | 6 | 147 | 316 | $17,840 | $9,574 |
Total Patients
827
Total Services
1,172
Medicare Billing
$49,617
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 23 | $4,017 | $1,769 | 44.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,948 | $577.06 | 19.6% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 77 | 79 | $15,800 | $11,148 | 70.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 158 | 163 | $20,375 | $8,269 | 40.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 89 | 89 | $15,219 | $2,357 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,836 | $442.33 | 24.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 26 | 29 | $290.00 | $86.01 | 29.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 17 | $170.00 | $37.78 | 22.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 51 | $7,650 | $4,441 | 58.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 53 | $7,191 | $3,422 | 47.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $4,060 | $2,225 | 54.8% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 36 | 36 | $4,196 | $1,986 | 47.3% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 44 | 44 | $3,520 | $1,821 | 51.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 14 | 14 | $1,750 | $718.34 | 41.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 16 | 16 | $1,240 | $565.28 | 45.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 19 | $475.00 | $158.55 | 33.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 16 | 170 | $425.00 | $20.22 | 4.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 45 | $6,135 | $3,162 | 51.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 25 | 25 | $3,175 | $2,192 | 69.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 34 | $4,380 | $2,005 | 45.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $3,100 | $1,964 | 63.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 18 | 25 | $625.00 | $234.00 | 37.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 16 | 170 | $425.00 | $17.22 | 4.1% |
About Randi Ballard-Dickerson, DNP, FNP-C
Randi Ballard-Dickerson, DNP, FNP-C is a Family healthcare provider based in Flint, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2019. The National Provider Identifier (NPI) number assigned to this provider is 1164982229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Randi Ballard-Dickerson, DNP, FNP-C has received a total of $1,277 in payments from pharmaceutical and medical device companies, with $720.15 received in 2024. These payments were reported across 85 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,277).
As a Medicare-enrolled provider, Ballard-Dickerson has provided services to 827 Medicare beneficiaries, totaling 1,172 services with total Medicare billing of $49,617. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Flint, MI
- Active Since 03/23/2019
- Last Updated 03/23/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164982229
Products in Payments
- VRAYLAR (Drug) $334.24
- REXULTI (Drug) $117.80
- Wegovy (Drug) $100.58
- Ozempic (Drug) $99.43
- NURTEC ODT (Drug) $73.95
- JARDIANCE (Drug) $72.66
- Cologuard Collection Kit (Device) $67.33
- CAPLYTA (Drug) $50.29
- Auvelity (Drug) $40.45
- ACCRUFER (Drug) $34.44
- MOUNJARO (Drug) $34.06
- TRINTELLIX (Drug) $32.12
- QUVIVIQ (Drug) $30.21
- UBRELVY (Drug) $29.70
- QULIPTA (Drug) $22.98
- TRELEGY ELLIPTA (Drug) $18.10
- Dexcom G6 Transmitter (Medical Supply) $17.64
- Otezla (Drug) $17.50
- FARXIGA (Drug) $13.93
- Veklury (Drug) $13.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Flint
Ms. Rachael Compeau, Np, NP
Family — Payments: $50,926
Family $50,926
Laura Szakal, Fnp-C, FNP-C
Family — Payments: $8,191
Family $8,191
Angela White, Fnp-Bc, FNP-BC
Family — Payments: $5,241
Family $5,241
Stephanie Ostrander, Fnp, FNP
Family — Payments: $3,914
Family $3,914
Jenny Dudley, Np-C, NP-C
Family — Payments: $3,448
Family $3,448
Julie Widzinski, Fnp-Bc, FNP-BC
Family — Payments: $3,053
Family $3,053